Drug intelligence / Profile preview

biphenyl dimethyl dicarboxylate + garlic oil

Development stage: Phase 4
Lead developer: PharmaKing
Modality: Nucleic Acid-Directed Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration: Oral

Overview

Pennel is an oral combination drug used primarily for liver dysfunction. It contains two active ingredients: biphenyl dimethyl dicarboxylate (DDB) and garlic oil. The combination is designed to provide synergistic effects, with DDB known for its hepatoprotective properties and garlic oil contributing additional antioxidant and potential detoxifying benefits. Pennel is marketed as a therapy to support liver health and function[1][3].

Brand names: Pennel
Other names: Pennel

Beyond the preview

Go deeper on biphenyl dimethyl dicarboxylate + garlic oil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on biphenyl dimethyl dicarboxylate + garlic oil.

Explore the full profile